Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology

Author(s): Cheon J, Lee JH


Current biomedical imaging techniques including magnetic resonance imaging (MRI), positron emission tomography (PET), and computed X-ray tomography (CT) are vital in the diagnosis of various diseases. Each imaging modality has its own merits and disadvantages, and a single technique does not possess all the required capabilities for comprehensive imaging. Therefore, multimodal imaging methods are quickly becoming important tools for state-of-the-art biomedical research and clinical diagnostics and therapeutics.

In this Account, we will discuss synergistically integrated nanoparticle probes, which will be an essential tool in multimodal imaging technology. When inorganic nanoparticles are introduced into biological systems, their extremely small size and their exceptional physical and chemical properties make them useful probes for biological diagnostics. Nanoparticle probes can endow imaging techniques with enhanced signal sensitivity, better spatial resolution, and the ability to relay information about biological systems at the molecular and cellular levels.

Simple magnetic nanoparticles function as MRI contrast enhancement probes. These magnetic nanoparticles can then serve as a core platform for the addition of other functional moieties including fluorescence tags, radionuclides, and other biomolecules for multimodal imaging, gene delivery, and cellular trafficking. For example, MRI−optical dual-modal probes composed of a fluorescent dye-doped silica (DySiO2) core surrounded by magnetic nanoparticles can macroscopically detect neuroblastoma cancer cells via MRI along with subcellular information via fluorescence imaging.

Magnetic nanoparticles can also be coupled to radionuclides (124I) to construct MRI−PET dual-modal probes. Such probes can accurately detect lymph nodes (LNs), which are critical for assessing cancer metastasis. In vivo MRI/PET images can clearly identify small (∼3 mm) LNs along with precise anatomical information. Systems using multicomponent nanoparticles modified with biomolecules can also monitor gene expression and other markers in cell therapeutics studies. We have used hybrid stem cell−magnetic nanoparticle probes with MRI to monitor in vivo stem cell trafficking. MRI with hybrid probes of magnetic nanoparticles and adenovirus can detect target cells and can monitor gene delivery and the expression of green fluorescent proteins optically. Each component of such multimodal probes complements the other modalities, and their synergistic materials properties ultimately provide more accurate information in in vitro and in vivo biological systems.

Similar Articles

Hallmarks of cancer: the next generation

Author(s): Hanahan D, Weinberg RA

Side effects of chemotherapy

Author(s): Burstein HJ

Therapeutic nanoparticles for drug delivery in cancer

Author(s): Cho K, Wang X, Nie S, Chen ZG, Shin DM

Synthesis of biocompatible Au–ZnTe core–shell nanoparticles

Author(s): Dunpall R, Lewis EA, Haigh SJ, O'Brien P, Revaprasadu N

Nanomaterial cytotoxicity is composition, size, and cell type dependent

Author(s): Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L

Nanoparticle and targeted systems for cancer therapy

Author(s): Brannon-Peppas L, Blanchette JO

Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform

Author(s): Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P,et al.